Together We Create Value

HeadsUp: Cmed joins the Aixial Group

Read the press release

Welcome to Cmed

HeadsUp: We are where Technology meets Expertise

Find out what makes us special

Oncology, Cell & Gene Therapy Expertise

HeadsUp: Our full-service CRO solutions are focused in oncology, immuno-oncology, cell & gene therapy and rare diseases

See the customised solutions that set us apart

Clinical Data Science to Conduct Trials of the Future

HeadsUp: We specialize in data management and biostatistics solutions across all therapeutic areas

Unleash the full potential for your valuable data

Together we can help progress your next clinical trial despite COVID-19 disruption

HeadsUp: We have the flexibility to navigate the challenges of a changing landscape with technology and expertise

Thank you for sharing your clinical journey with us

HeadsUp: Cmed celebrates 20 years

Here's how we've put customers first

#HeadsUp

Cmed announces it joins the AIXIAL Group, part of ALTEN, and continues to expand its global reach and service offering. This very synergistic combination enables Cmed to support its valued customers by creating a unique, fully integrated Technology-led CRO offering an end-to-end partner.

Cmed is Where Technology Meets Expertise. No other CRO is better prepared to support Biotech and Biopharma sponsors deliver the future of clinical trials.

Technology-led and with specialty expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered the processes for delivering next generation trials.

As the global pharmaceutical industry continues to undergo seismic change, our 20 years of innovation, commitment and expertise enable us to embrace radical disruption and transform the clinical trials landscape for the benefit of patients.

We anticipate. We adapt. We embrace every challenge. We are where you want to be.